Annual EBIT:
$575.23M+$208.14M(+56.70%)Summary
- As of today, HALO annual earnings before interest & taxes is $575.23 million, with the most recent change of +$208.14 million (+56.70%) on December 31, 2024.
- During the last 3 years, HALO annual EBIT has risen by +$319.18 million (+124.66%).
- HALO annual EBIT is now at all-time high.
Performance
HALO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$209.33M+$60.98M(+41.10%)Summary
- As of today, HALO quarterly earnings before interest & taxes is $209.33 million, with the most recent change of +$60.98 million (+41.10%) on June 30, 2025.
- Over the past year, HALO quarterly EBIT has increased by +$87.06 million (+71.21%).
- HALO quarterly EBIT is now at all-time high.
Performance
HALO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$710.11M+$87.06M(+13.97%)Summary
- As of today, HALO TTM earnings before interest & taxes is $710.11 million, with the most recent change of +$87.06 million (+13.97%) on June 30, 2025.
- Over the past year, HALO TTM EBIT has increased by +$274.65 million (+63.07%).
- HALO TTM EBIT is now at all-time high.
Performance
HALO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HALO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +56.7% | +71.2% | +63.1% |
| 3Y3 Years | +124.7% | +532.1% | +193.4% |
| 5Y5 Years | +1048.8% | +577.9% | +1646.2% |
HALO EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +124.7% | at high | +268.7% | at high | +188.1% |
| 5Y | 5-Year | at high | +1048.8% | at high | +596.6% | at high | +1646.2% |
| All-Time | All-Time | at high | +802.5% | at high | +781.2% | at high | +832.8% |
HALO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $209.33M(+41.1%) | $710.11M(+14.0%) |
| Mar 2025 | - | $148.35M(-18.8%) | $623.04M(+8.3%) |
| Dec 2024 | $575.23M(+56.7%) | $182.75M(+7.7%) | $575.23M(+15.3%) |
| Sep 2024 | - | $169.67M(+38.8%) | $498.87M(+14.6%) |
| Jun 2024 | - | $122.27M(+21.6%) | $435.46M(+6.0%) |
| Mar 2024 | - | $100.53M(-5.5%) | $410.85M(+11.9%) |
| Dec 2023 | $367.09M(+38.1%) | $106.39M(+0.1%) | $367.09M(+9.2%) |
| Sep 2023 | - | $106.27M(+8.8%) | $336.06M(+8.1%) |
| Jun 2023 | - | $97.65M(+72.0%) | $311.01M(+26.2%) |
| Mar 2023 | - | $56.78M(-24.7%) | $246.48M(-7.3%) |
| Dec 2022 | $265.87M(+3.8%) | $75.36M(-7.2%) | $265.87M(+7.5%) |
| Sep 2022 | - | $81.22M(+145.3%) | $247.37M(+2.2%) |
| Jun 2022 | - | $33.12M(-56.5%) | $242.01M(-19.9%) |
| Mar 2022 | - | $76.17M(+33.9%) | $302.16M(+18.0%) |
| Dec 2021 | $256.04M(+71.1%) | $56.87M(-25.0%) | $256.04M(-7.7%) |
| Sep 2021 | - | $75.86M(-18.7%) | $277.46M(+14.2%) |
| Jun 2021 | - | $93.27M(+210.4%) | $242.86M(+34.6%) |
| Mar 2021 | - | $30.05M(-61.6%) | $180.47M(+20.6%) |
| Dec 2020 | $149.68M(+346.9%) | $78.28M(+89.7%) | $149.68M(+268.1%) |
| Sep 2020 | - | $41.26M(+33.6%) | $40.67M(+272.9%) |
| Jun 2020 | - | $30.88M(+4250.4%) | -$23.52M(+64.6%) |
| Mar 2020 | - | -$744.00K(+97.6%) | -$66.39M(-9.5%) |
| Dec 2019 | -$60.62M(+1.8%) | -$30.73M(-34.0%) | -$60.62M(-116.9%) |
| Sep 2019 | - | -$22.92M(-91.1%) | -$27.95M(+2.2%) |
| Jun 2019 | - | -$11.99M(-338.8%) | -$28.59M(+17.6%) |
| Mar 2019 | - | $5.02M(+158.1%) | -$34.69M(+43.8%) |
| Dec 2018 | -$61.75M(-173.9%) | $1.95M(+108.3%) | -$61.75M(-197.5%) |
| Sep 2018 | - | -$23.56M(-30.3%) | $63.31M(-33.9%) |
| Jun 2018 | - | -$18.09M(+17.9%) | $95.74M(+7.8%) |
| Mar 2018 | - | -$22.04M(-117.4%) | $88.79M(+6.2%) |
| Dec 2017 | $83.59M(+202.1%) | $127.01M(+1332.4%) | $83.59M(+227.4%) |
| Sep 2017 | - | $8.87M(+135.4%) | -$65.62M(+32.3%) |
| Jun 2017 | - | -$25.04M(+8.1%) | -$96.90M(-4.0%) |
| Mar 2017 | - | -$27.24M(-22.6%) | -$93.18M(-13.8%) |
| Dec 2016 | -$81.88M(-202.9%) | -$22.21M(+0.9%) | -$81.88M(-51.5%) |
| Sep 2016 | - | -$22.41M(-5.1%) | -$54.05M(+1.4%) |
| Jun 2016 | - | -$21.33M(-33.8%) | -$54.80M(-87.9%) |
| Mar 2016 | - | -$15.94M(-383.6%) | -$29.16M(-7.9%) |
| Dec 2015 | -$27.03M(+57.0%) | $5.62M(+124.3%) | -$27.03M(+26.0%) |
| Sep 2015 | - | -$23.16M(-636.3%) | -$36.55M(-13.2%) |
| Jun 2015 | - | $4.32M(+131.3%) | -$32.29M(+37.2%) |
| Mar 2015 | - | -$13.81M(-254.4%) | -$51.43M(+18.1%) |
| Dec 2014 | -$62.79M(+21.7%) | -$3.90M(+79.4%) | -$62.79M(+21.7%) |
| Sep 2014 | - | -$18.90M(-27.5%) | -$80.16M(-0.6%) |
| Jun 2014 | - | -$14.82M(+41.1%) | -$79.70M(+8.3%) |
| Mar 2014 | - | -$25.17M(-18.4%) | -$86.94M(-8.4%) |
| Dec 2013 | -$80.20M | -$21.26M(-15.3%) | -$80.20M(-26.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$18.44M(+16.4%) | -$63.35M(+2.4%) |
| Jun 2013 | - | -$22.06M(-19.6%) | -$64.91M(-14.1%) |
| Mar 2013 | - | -$18.44M(-318.5%) | -$56.87M(-6.2%) |
| Dec 2012 | -$53.55M(-170.9%) | -$4.41M(+78.0%) | -$53.55M(+20.7%) |
| Sep 2012 | - | -$20.01M(-42.7%) | -$67.51M(-59.4%) |
| Jun 2012 | - | -$14.02M(+7.3%) | -$42.35M(-67.8%) |
| Mar 2012 | - | -$15.12M(+17.6%) | -$25.23M(-27.6%) |
| Dec 2011 | -$19.77M(+63.6%) | -$18.36M(-456.3%) | -$19.77M(-2.5%) |
| Sep 2011 | - | $5.15M(+66.4%) | -$19.29M(+47.7%) |
| Jun 2011 | - | $3.10M(+132.0%) | -$36.88M(+29.3%) |
| Mar 2011 | - | -$9.66M(+46.0%) | -$52.13M(+3.9%) |
| Dec 2010 | -$54.26M(+7.2%) | -$17.88M(-43.8%) | -$54.26M(-10.6%) |
| Sep 2010 | - | -$12.43M(-2.3%) | -$49.05M(+3.0%) |
| Jun 2010 | - | -$12.15M(-3.1%) | -$50.56M(+8.9%) |
| Mar 2010 | - | -$11.79M(+7.0%) | -$55.49M(+5.1%) |
| Dec 2009 | -$58.46M(-15.9%) | -$12.68M(+9.1%) | -$58.46M(+6.9%) |
| Sep 2009 | - | -$13.94M(+18.4%) | -$62.81M(-4.6%) |
| Jun 2009 | - | -$17.08M(-15.8%) | -$60.07M(-10.5%) |
| Mar 2009 | - | -$14.76M(+13.3%) | -$54.36M(-7.8%) |
| Dec 2008 | -$50.43M(-79.2%) | -$17.03M(-52.0%) | -$50.43M(-16.4%) |
| Sep 2008 | - | -$11.20M(+1.5%) | -$43.34M(-7.1%) |
| Jun 2008 | - | -$11.37M(-5.0%) | -$40.45M(-15.9%) |
| Mar 2008 | - | -$10.83M(-9.1%) | -$34.90M(-24.0%) |
| Dec 2007 | -$28.15M(-80.6%) | -$9.93M(-19.5%) | -$28.15M(-23.0%) |
| Sep 2007 | - | -$8.31M(-42.5%) | -$22.89M(-24.4%) |
| Jun 2007 | - | -$5.83M(-42.9%) | -$18.41M(-15.1%) |
| Mar 2007 | - | -$4.08M(+12.6%) | -$15.99M(-2.6%) |
| Dec 2006 | -$15.58M(-14.9%) | -$4.67M(-22.0%) | -$15.58M(-7.5%) |
| Sep 2006 | - | -$3.83M(-12.0%) | -$14.49M(-0.4%) |
| Jun 2006 | - | -$3.42M(+7.0%) | -$14.43M(-3.4%) |
| Mar 2006 | - | -$3.67M(-2.6%) | -$13.96M(-3.0%) |
| Dec 2005 | -$13.56M(-49.2%) | -$3.58M(+5.0%) | -$13.56M(-8.4%) |
| Sep 2005 | - | -$3.77M(-27.8%) | -$12.51M(-4.2%) |
| Jun 2005 | - | -$2.95M(+9.9%) | -$12.01M(-7.7%) |
| Mar 2005 | - | -$3.27M(-29.4%) | -$11.15M(-22.7%) |
| Dec 2004 | -$9.09M(>-9900.0%) | -$2.53M(+22.5%) | -$9.09M(-64.4%) |
| Sep 2004 | - | -$3.26M(-56.2%) | -$5.53M(-106.8%) |
| Jun 2004 | - | -$2.09M(-73.0%) | -$2.67M(-179.5%) |
| Mar 2004 | - | -$1.21M(-217.0%) | -$956.20K(>-9900.0%) |
| Dec 2003 | $0.00(0.0%) | $1.03M(+352.9%) | $0.00(+100.0%) |
| Sep 2003 | - | -$408.20K(-9.5%) | -$1.01M(-64.0%) |
| Jun 2003 | - | -$372.90K(-48.3%) | -$618.40K(-134.4%) |
| Mar 2003 | - | -$251.40K(-1458.9%) | -$263.80K(>-9900.0%) |
| Dec 2002 | $0.00(+100.0%) | $18.50K(+246.8%) | $0.00(+100.0%) |
| Sep 2002 | - | -$12.60K(+31.1%) | -$18.50K(-213.6%) |
| Jun 2002 | - | -$18.30K(-247.6%) | -$5900.00(-147.6%) |
| Mar 2002 | - | $12.40K | $12.40K |
| Dec 2001 | -$39.70K | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual EBIT year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM EBIT year-on-year change?
What is Halozyme Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of HALO is $575.23M
What is the all-time high annual EBIT for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual earnings before interest & taxes is $575.23M
What is Halozyme Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, HALO annual earnings before interest & taxes has changed by +$208.14M (+56.70%)
What is Halozyme Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of HALO is $209.33M
What is the all-time high quarterly EBIT for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $209.33M
What is Halozyme Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, HALO quarterly earnings before interest & taxes has changed by +$87.06M (+71.21%)
What is Halozyme Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of HALO is $710.11M
What is the all-time high TTM EBIT for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $710.11M
What is Halozyme Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, HALO TTM earnings before interest & taxes has changed by +$274.65M (+63.07%)